APRE: Aprea Therapeutics, Inc. Stock

by  •  • Comments Off on APRE: Aprea Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 13.48
Enterprise Value ($M) -11.46
Book Value ($M) 23.26
Book Value / Share 4.28
Price / Book 0.58
NCAV ($M) 22.85
NCAV / Share 4.20
Price / NCAV 0.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.58
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 7.28
Current Ratio 7.28

Balance Sheet (mrq) ($M)
Current Assets 26.48
Assets 26.89
Liabilities 3.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Stonepine Capital Management, LLC 5.10 -21.63
11-14 13G Nantahala Capital Management, LLC 7.30
2024-02-14 13G Sio Capital Management, LLC 7.49
2024-02-07 13G/A Hirschman Orin 9.40 1.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 1,053 9,931 10.60
2025-03-06 283 5,332 5.31
2025-03-05 7,456 10,736 69.45
2025-03-04 20,712 70,892 29.22

(click for more detail)

Similar Companies
ANEB – Anebulo Pharmaceuticals, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited APTO – Aptose Biosciences Inc.
APVO – Aptevo Therapeutics Inc.


Financial data and stock pages provided by
Fintel.io